A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults
358-201-00001
Phase 1 other active
Quick answer
A Trial to Examine the Effects of MSP-2020 on Brain Activity in Healthy Adults for Incomplete Response - Major Depressive Disorder (IR-MDD) is a Phase 1 program (other) at Otsuka Novel Products GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Otsuka Novel Products GmbH
- Indication
- Incomplete Response - Major Depressive Disorder (IR-MDD)
- Phase
- Phase 1
- Modality
- other
- Status
- active